229 related articles for article (PubMed ID: 36908260)
1. Endothelial-to-mesenchymal transition in tumour progression and its potential roles in tumour therapy.
Yin Z; Wang L
Ann Med; 2023 Dec; 55(1):1058-1069. PubMed ID: 36908260
[TBL] [Abstract][Full Text] [Related]
2. Roles of TGF-β signals in tumor microenvironment via regulation of the formation and plasticity of vascular system.
Watabe T; Takahashi K; Pietras K; Yoshimatsu Y
Semin Cancer Biol; 2023 Jul; 92():130-138. PubMed ID: 37068553
[TBL] [Abstract][Full Text] [Related]
3. CD40 is expressed in the subsets of endothelial cells undergoing partial endothelial-mesenchymal transition in tumor microenvironment.
Takahashi K; Kobayashi M; Katsumata H; Tokizaki S; Anzai T; Ikeda Y; Alcaide DM; Maeda K; Ishihara M; Tahara K; Kubota Y; Itoh F; Park J; Takahashi K; Matsunaga YT; Yoshimatsu Y; Podyma-Inoue KA; Watabe T
Cancer Sci; 2024 Feb; 115(2):490-506. PubMed ID: 38111334
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblast-derived PAI-1 promotes lymphatic metastasis via the induction of EndoMT in lymphatic endothelial cells.
Wei WF; Zhou HL; Chen PY; Huang XL; Huang L; Liang LJ; Guo CH; Zhou CF; Yu L; Fan LS; Wang W
J Exp Clin Cancer Res; 2023 Jul; 42(1):160. PubMed ID: 37415190
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of hypoxia on early endothelial-mesenchymal transition response to transforming growth beta isoforms 1 and 2.
Doerr M; Morrison J; Bergeron L; Coomber BL; Viloria-Petit A
Microvasc Res; 2016 Nov; 108():48-63. PubMed ID: 27503671
[TBL] [Abstract][Full Text] [Related]
6. Aneuploid Circulating Tumor-Derived Endothelial Cell (CTEC): A Novel Versatile Player in Tumor Neovascularization and Cancer Metastasis.
Lin PP
Cells; 2020 Jun; 9(6):. PubMed ID: 32599893
[TBL] [Abstract][Full Text] [Related]
7. Endothelial-to-Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction.
Haynes BA; Yang LF; Huyck RW; Lehrer EJ; Turner JM; Barabutis N; Correll VL; Mathiesen A; McPheat W; Semmes OJ; Dobrian AD
Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):2168-2191. PubMed ID: 31434495
[TBL] [Abstract][Full Text] [Related]
8. Tumour endothelial cells acquire drug resistance in a tumour microenvironment.
Hida K; Akiyama K; Ohga N; Maishi N; Hida Y
J Biochem; 2013 Mar; 153(3):243-9. PubMed ID: 23293323
[TBL] [Abstract][Full Text] [Related]
9. Endothelial-to-mesenchymal transition: Pathogenesis and therapeutic targets for chronic pulmonary and vascular diseases.
Lu X; Gong J; Dennery PA; Yao H
Biochem Pharmacol; 2019 Oct; 168():100-107. PubMed ID: 31251941
[TBL] [Abstract][Full Text] [Related]
10. Emerging roles of inflammation-mediated endothelial-mesenchymal transition in health and disease.
Yoshimatsu Y; Watabe T
Inflamm Regen; 2022 Feb; 42(1):9. PubMed ID: 35130955
[TBL] [Abstract][Full Text] [Related]
11. Reassessing endothelial-to-mesenchymal transition in cardiovascular diseases.
Li Y; Lui KO; Zhou B
Nat Rev Cardiol; 2018 Aug; 15(8):445-456. PubMed ID: 29748594
[TBL] [Abstract][Full Text] [Related]
12. Endothelial-to-Mesenchymal Transition (EndoMT): Roles in Tumorigenesis, Metastatic Extravasation and Therapy Resistance.
Platel V; Faure S; Corre I; Clere N
J Oncol; 2019; 2019():8361945. PubMed ID: 31467544
[TBL] [Abstract][Full Text] [Related]
13. Endothelial-mesenchymal transition in normal human esophageal endothelial cells cocultured with esophageal adenocarcinoma cells: role of IL-1β and TGF-β2.
Nie L; Lyros O; Medda R; Jovanovic N; Schmidt JL; Otterson MF; Johnson CP; Behmaram B; Shaker R; Rafiee P
Am J Physiol Cell Physiol; 2014 Nov; 307(9):C859-77. PubMed ID: 25163519
[TBL] [Abstract][Full Text] [Related]
14. N-Cadherin Targeted Melanin Nanoparticles Reverse the Endothelial-Mesenchymal Transition in Vascular Endothelial Cells to Potentially Slow the Progression of Atherosclerosis and Cancer.
Liu J; Yu X; Braucht A; Smith S; Wang C
ACS Nano; 2024 Mar; 18(11):8229-8247. PubMed ID: 38427686
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-155 functions as a negative regulator of RhoA signaling in TGF-β-induced endothelial to mesenchymal transition.
Bijkerk R; de Bruin RG; van Solingen C; Duijs JM; Kobayashi K; van der Veer EP; ten Dijke P; Rabelink TJ; Goumans MJ; van Zonneveld AJ
Microrna; 2012; 1(1):2-10. PubMed ID: 25048084
[TBL] [Abstract][Full Text] [Related]
16. Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis.
Singh B; Cui K; Eisa-Beygi S; Zhu B; Cowan DB; Shi J; Wang DZ; Liu Z; Bischoff J; Chen H
Vascul Pharmacol; 2024 Jun; 155():107368. PubMed ID: 38548093
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome analysis reveals molecular signature and cell-type difference of Homo sapiens endothelial-to-mesenchymal transition.
Bronson R; Lyu J; Xiong J
G3 (Bethesda); 2023 Dec; 13(12):. PubMed ID: 37857450
[TBL] [Abstract][Full Text] [Related]
18. miRNA-200c-3p promotes endothelial to mesenchymal transition and neointimal hyperplasia in artery bypass grafts.
Chen D; Zhang C; Chen J; Yang M; Afzal TA; An W; Maguire EM; He S; Luo J; Wang X; Zhao Y; Wu Q; Xiao Q
J Pathol; 2021 Feb; 253(2):209-224. PubMed ID: 33125708
[TBL] [Abstract][Full Text] [Related]
19. A role for partial endothelial-mesenchymal transitions in angiogenesis?
Welch-Reardon KM; Wu N; Hughes CC
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):303-8. PubMed ID: 25425619
[TBL] [Abstract][Full Text] [Related]
20. Inflammation-induced endothelial to mesenchymal transition promotes brain endothelial cell dysfunction and occurs during multiple sclerosis pathophysiology.
Derada Troletti C; Fontijn RD; Gowing E; Charabati M; van Het Hof B; Didouh I; van der Pol SMA; Geerts D; Prat A; van Horssen J; Kooij G; de Vries HE
Cell Death Dis; 2019 Jan; 10(2):45. PubMed ID: 30718504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
